ADIPOQ and chronic kidney disease: IL-6 causes endothelial injury mainly by reducing the expressions of endothelial nitric oxide synthase and adiponectin (an anti-atherogenic adipokine), thereby contributing to an increased incidence of chronic vascular disease, progression of CKD, and a rapid renal function decline [27,31].